DreamFold leverages generative AI algorithms in the design of protein therapeutics to address significant biological challenges related to human disease.
DreamFold is building a next-generation protein therapeutics platform that combines advanced AI-driven protein design, generative modelling, and high-throughput screening to rapidly create new classes of protein drugs. DreamFold aims to transform outcomes for patients who currently lack safe, effective treatments.
DreamFold was founded at MILA, a globally renowned AI research institute.
